VTYX Articles, Ventyx Biosciences Inc. - From 03/11/24

Investors can contact the law firm at no cost to learn more about recovering their losses ?LOS ANGELES, March 11, 2024 (GLOBE NEWSWIRE) -- The...

VTX3232 was well-tolerated in the Phase 1 trial with robust target coverage achieved in both plasma and CSF; Ventyx is planning to initiate Phase ...

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of Smith & Wesson Brands, Inc. (NASDAQ: SWBI)...

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ventyx Biosciences, Inc. ("Ventyx" or the &...

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc....

SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx"), a clinical-stage biopharmaceutical company focu...

NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, not...

NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action law...

SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all those who...

NEW YORK, March 04, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in th...